Official SEC submissions
CNS Pharmaceuticals SEC Filings
Direct answer
CNS Pharmaceuticals's latest SEC filing is 8-K.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Recent SEC filings
DEF 14A
Proxy statement
Filed:
Report date:
DEFINITIVE NOTICE AND PROXY STATEMENT
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
10-K/A
Periodic report
Filed:
Report date:
AMENDMENT #1 TO FORM 10-K
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
10-K/A
Periodic report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 10-K
Verified data
- Recent filing categories
- 5
- Recent filings
- 40
- SEC CIK
- 0001729427
- Latest filing date
- October 2, 2026